These results demonstrate that ABL kinase activity is required
for osteolytic metastasis in breast cancer and suggest that pharmacological inhibition of the ABL kinases may be an effective treatment for bone metastasis.
Our data raise the possibility that inhibition of ABL kinases can increase apoptosis of breast cancer cells and block osteoclast activation, which is required
for osteolytic metastasis.
Not exact matches
In the bone metastatic microenvironment, the crosstalk between metastasized cancer cells and the surrounding bone cells is critical
for the formation of the osteoblastic or
osteolytic phenotype.
ADAMTS1 and MMP1 proteolytically engage EGF - like ligands in an
osteolytic signaling cascade
for bone metastasis
For most patients with breast cancer, bone metastases are predominantly
osteolytic.
Sometimes biopsy of
osteolytic lesions is needed
for diagnosis.